Introduction: Biotechnology and Nutrition in India’s Bioeconomy

India’s biotechnology industry is a critical pillar of the nation’s bioeconomy, valued at approximately USD 70 billion in 2023 according to the Department of Biotechnology (DBT). This sector integrates innovations such as gene editing, bioprinting, and sustainable biological resource utilization to enhance both human and animal nutrition. The industry’s growth is supported by regulatory frameworks like the Environment Protection Act, 1986 and the Biological Diversity Act, 2002, alongside institutional actors including the Genetic Engineering Appraisal Committee (GEAC) and the Food Safety and Standards Authority of India (FSSAI). These developments contribute to economic growth, food security, and environmental sustainability.

Defining Bioeconomy and Its Components

The bioeconomy refers to the production of renewable biological resources and their conversion into food, bio-based products, and energy. It integrates sectors such as agriculture, animal husbandry, and industrial biotechnology. Innovations like gene editing (e.g., CRISPR-Cas9) and bioprinting enable precise modification of organisms to improve nutritional profiles and disease resistance.

• Bioeconomy promotes circular economy principles by recycling biomass and reducing waste.
• Integration with digital technologies enhances traceability and efficiency in biotech applications.
• It addresses environmental challenges by reducing reliance on chemical inputs and fossil fuels.

India’s Biotechnology Sector: Scale, Growth, and Segments

India ranks among the top 12 global biotech destinations, contributing 3% to the global bioeconomy (Biospectrum India Report, 2023). The sector’s market size grew from USD 10 billion in 2014 to USD 70 billion in 2023, with a projected CAGR of 15-20% over 2023-2028 (DBT Annual Report, 2023). The animal nutrition segment, driven by biotech feed additives and probiotics, is expected to grow at 8% annually (FICCI Report, 2023).

• Biotech sub-sectors include biopharmaceuticals, bio-agriculture, bio-IT, and bio-services.
• Government allocated INR 2,800 crore for biotechnology in 2023-24, focusing on translational research.
• Biotech exports reached USD 2.5 billion in 2022-23, growing at 12% year-on-year.

Regulatory Framework Governing Biotechnology in India

Biotechnology regulation in India is governed primarily by:

• Environment Protection Act, 1986: Section 6 and the 1989 Rules regulate manufacture, use, import, export, and storage of hazardous microorganisms and genetically engineered organisms.
• Biological Diversity Act, 2002: Sections 3-6 govern access to biological resources and equitable benefit sharing.
• Food Safety and Standards Act, 2006: Sections 22-24 regulate food additives and safety standards for biotech-derived food products.

The Genetic Engineering Appraisal Committee (GEAC) under the Ministry of Environment, Forest and Climate Change (MoEFCC) is the apex regulatory body for approving genetically modified organisms (GMOs). The Food Safety and Standards Authority of India (FSSAI) oversees safety standards for biotech foods.

Key Institutions Driving Biotech Innovation and Regulation

• Department of Biotechnology (DBT): Policy formulation, funding, and coordination of biotech R&D.
• Indian Council of Agricultural Research (ICAR): Implements biotech innovations in agriculture and animal husbandry.
• Genetic Engineering Appraisal Committee (GEAC): Regulatory authority for GMOs.
• Food Safety and Standards Authority of India (FSSAI): Food safety regulation including biotech-derived products.
• ICAR-National Institute on Veterinary Epidemiology and Disease Informatics (NIVEDI): Focus on animal nutrition and health research.
• Biotechnology Industry Research Assistance Council (BIRAC): Supports biotech startups and industry-academia linkages.

Comparative Analysis: India vs USA in Biotechnology and Bioeconomy

Challenges and Critical Gaps in India’s Biotech Sector

• Regulatory delays and complex approval processes hinder rapid commercialization.
• Fragmented policy implementation across ministries and states reduces efficiency.
• Limited public-private partnerships restrict scaling of research into market-ready animal nutrition products.
• Infrastructure gaps and funding constraints affect translational research.
• Comparatively slower adoption of digital integration and innovation ecosystems than global peers.

Significance and Way Forward

• Streamline GEAC and FSSAI approval processes to reduce regulatory bottlenecks.
• Enhance coordination between DBT, ICAR, and industry stakeholders for focused translational research.
• Promote public-private partnerships and startup incubation through BIRAC and similar platforms.
• Leverage digital technologies such as AI and big data for precision nutrition and monitoring.
• Expand investment in animal nutrition biotech to improve livestock productivity and nutritional security.

Jharkhand & JPSC Relevance

• JPSC Paper: Paper 3 - Agriculture and Animal Husbandry; Biotechnology applications in livestock nutrition
• Jharkhand Angle: Jharkhand’s livestock sector can benefit from biotech feed additives and probiotics to improve animal health and productivity, supporting rural livelihoods.
• Mains Pointer: Frame answers by linking state-specific animal husbandry challenges with biotech solutions and institutional support from ICAR-NIVEDI and DBT initiatives.